BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ellis HP, Kurian KM. Biological Rationale for the Use of PPARγ Agonists in Glioblastoma. Front Oncol 2014;4:52. [PMID: 24672773 DOI: 10.3389/fonc.2014.00052] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Im C. Targeting glioblastoma stem cells (GSCs) with peroxisome proliferator-activated receptor gamma (PPARγ) ligands: Targeting GSCs with PPARγ Ligands. IUBMB Life 2016;68:173-7. [DOI: 10.1002/iub.1475] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
2 Ye Q, Huang W, Li D, Si E, Wang J, Wang Y, Chen C, Chen X. Overexpression of PGC-1α Influences Mitochondrial Signal Transduction of Dopaminergic Neurons. Mol Neurobiol 2016;53:3756-70. [PMID: 26141122 DOI: 10.1007/s12035-015-9299-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
3 Szoka L, Palka J. Capsaicin up-regulates pro-apoptotic activity of thiazolidinediones in glioblastoma cell line. Biomed Pharmacother 2020;132:110741. [PMID: 33038582 DOI: 10.1016/j.biopha.2020.110741] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cilibrasi C, Butta V, Riva G, Bentivegna A. Pioglitazone Effect on Glioma Stem Cell Lines: Really a Promising Drug Therapy for Glioblastoma? PPAR Res 2016;2016:7175067. [PMID: 27313600 DOI: 10.1155/2016/7175067] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
5 Song N, Li XM, Luo JY, Zhai H, Zhao Q, Zhou XR, Liu F, Zhang XH, Gao XM, Li XM, Yang YN. Construction and analysis for differentially expressed long non-coding RNAs and mRNAs in acute myocardial infarction. Sci Rep 2020;10:6989. [PMID: 32332808 DOI: 10.1038/s41598-020-63840-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Clancy H, Pruski M, Lang B, Ching J, McCaig CD. Glioblastoma cell migration is directed by electrical signals. Exp Cell Res 2021;406:112736. [PMID: 34273404 DOI: 10.1016/j.yexcr.2021.112736] [Reference Citation Analysis]
7 DeTomaso D, Yosef N. FastProject: a tool for low-dimensional analysis of single-cell RNA-Seq data. BMC Bioinformatics 2016;17:315. [PMID: 27553427 DOI: 10.1186/s12859-016-1176-5] [Cited by in Crossref: 49] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
8 Doloff JC, Waxman DJ. Transcriptional profiling provides insights into metronomic cyclophosphamide-activated, innate immune-dependent regression of brain tumor xenografts. BMC Cancer 2015;15:375. [PMID: 25952672 DOI: 10.1186/s12885-015-1358-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
9 Im CN. Combination Treatment with PPARγ Ligand and Its Specific Inhibitor GW9662 Downregulates BIS and 14-3-3 Gamma, Inhibiting Stem-Like Properties in Glioblastoma Cells. Biomed Res Int 2017;2017:5832824. [PMID: 28642874 DOI: 10.1155/2017/5832824] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
10 Uram Ł, Misiorek M, Pichla M, Filipowicz-Rachwał A, Markowicz J, Wołowiec S, Wałajtys-Rode E. The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro. Molecules 2019;24:E3801. [PMID: 31652556 DOI: 10.3390/molecules24203801] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
11 Haynes HR, White P, Hares KM, Redondo J, Kemp KC, Singleton WGB, Killick-Cole CL, Stevens JR, Garadi K, Guglani S, Wilkins A, Kurian KM. The transcription factor PPARα is overexpressed and is associated with a favourable prognosis in IDH-wildtype primary glioblastoma. Histopathology 2017;70:1030-43. [PMID: 27926792 DOI: 10.1111/his.13142] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
12 Zhou D, Qu Z, Wang H, Su Y, Wang Y, Zhang W, Wang Z, Xu Q. The effect of hydroxy safflower yellow A on coronary heart disease through Bcl-2/Bax and PPAR-γ. Exp Ther Med 2018;15:520-6. [PMID: 29399062 DOI: 10.3892/etm.2017.5414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
13 Strickland M, Stoll EA. Metabolic Reprogramming in Glioma. Front Cell Dev Biol 2017;5:43. [PMID: 28491867 DOI: 10.3389/fcell.2017.00043] [Cited by in Crossref: 115] [Cited by in F6Publishing: 117] [Article Influence: 23.0] [Reference Citation Analysis]
14 Vella V, Nicolosi ML, Giuliano S, Bellomo M, Belfiore A, Malaguarnera R. PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis. Front Endocrinol (Lausanne) 2017;8:31. [PMID: 28275367 DOI: 10.3389/fendo.2017.00031] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 8.6] [Reference Citation Analysis]
15 Liu J, Qiu J, Zhang Z, Zhou L, Li Y, Ding D, Zhang Y, Zou D, Wang D, Zhou Q, Lang T. SOX4 maintains the stemness of cancer cells via transcriptionally enhancing HDAC1 revealed by comparative proteomics study. Cell Biosci 2021;11:23. [PMID: 33482915 DOI: 10.1186/s13578-021-00539-y] [Reference Citation Analysis]
16 Kalya M, Kel A, Wlochowitz D, Wingender E, Beißbarth T. IGFBP2 Is a Potential Master Regulator Driving the Dysregulated Gene Network Responsible for Short Survival in Glioblastoma Multiforme. Front Genet 2021;12:670240. [PMID: 34211498 DOI: 10.3389/fgene.2021.670240] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pouremamali F, Vahedian V, Hassani N, Mirzaei S, Pouremamali A, Kazemzadeh H, Faridvand Y, Jafari-gharabaghlou D, Nouri M, Maroufi NF. The role of SOX family in cancer stem cell maintenance: With a focus on SOX2. Pathology - Research and Practice 2022;231:153783. [DOI: 10.1016/j.prp.2022.153783] [Reference Citation Analysis]
18 Wang H, Yan X, Ji LY, Ji XT, Wang P, Guo SW, Li SZ. miR-139 Functions as An Antioncomir to Repress Glioma Progression Through Targeting IGF-1 R, AMY-1, and PGC-1β. Technol Cancer Res Treat 2017;16:497-511. [PMID: 26868851 DOI: 10.1177/1533034616630866] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
19 Huberfeld G, Vecht CJ. Seizures and gliomas — towards a single therapeutic approach. Nat Rev Neurol 2016;12:204-16. [DOI: 10.1038/nrneurol.2016.26] [Cited by in Crossref: 80] [Cited by in F6Publishing: 68] [Article Influence: 13.3] [Reference Citation Analysis]